Next earnings date: 22 Oct 2025
ResMed Inc. – NYSE:RMD
Founder-led company
ResMed stock price today
$283.7
+50.51
+21.67%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 8 hours
ResMed stock price monthly change
+13.84%
month
ResMed stock price quarterly change
+13.84%
quarter
ResMed stock price yearly change
+34.80%
year
ResMed key metrics
Market Cap | 33.04B |
Enterprise value | 34.65B |
P/E | 30.77 |
EV/Sales | 7.20 |
EV/EBITDA | 20.54 |
Price/Sales | 7.12 |
Price/Book | 6.59 |
PEG ratio | -38.61 |
EPS | 6.51 |
Revenue | 4.35B |
EBITDA | 1.41B |
Income | 957.71M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 23.15% |
Oper. margin | 29.5% |
Gross margin | 57.2% |
EBIT margin | 29.5% |
EBITDA margin | 32.42% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeResMed stock price history
ResMed stock forecast
ResMed financial statements
Average Price Target
$233.5
Potential downside: -17.69%
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 914.73M | 195.06M | 21.32% |
|---|---|---|---|
| Mar 2023 | 1.11B | 232.5M | 20.82% |
| Jun 2023 | 1.12B | 229.66M | 20.47% |
| Mar 2024 | 1.19B | 300.49M | 25.1% |
| 2024-10-24 | 2.04 | 2.2 |
|---|
0.86%
Yield TTM
| Payout ratio | 26.02% |
|---|
| 2020 | 0.81% |
|---|---|
| 2021 | 0.63% |
| 2022 | 0.8% |
| 2023 | 0.81% |
| 2024 | 1.03% |
| Dec 2022 | 6676104000 | 2.93B | 44.01% |
|---|---|---|---|
| Mar 2023 | 6713879000 | 2.78B | 41.43% |
| Jun 2023 | 6751708000 | 2.62B | 38.83% |
| Mar 2024 | 6814562000 | 2.18B | 32.06% |
| Jun 2022 | 79.48M | -55.24M | 57.49M |
|---|---|---|---|
| Mar 2023 | 282.56M | -28.10M | -279.55M |
| Jun 2023 | 237.43M | -46.52M | -188.59M |
| Mar 2024 | 402.03M | -33.15M | -335.91M |
ResMed alternative data
| Aug 2023 | 8,160 |
|---|---|
| Sep 2023 | 10,140 |
| Oct 2023 | 10,140 |
| Nov 2023 | 10,140 |
| Dec 2023 | 10,140 |
| Jan 2024 | 10,140 |
| Feb 2024 | 10,140 |
| Mar 2024 | 10,140 |
| Apr 2024 | 10,140 |
| May 2024 | 10,140 |
| Jun 2024 | 10,140 |
| Jul 2024 | 10,140 |
ResMed other data
64.79%
-0.55%
of RMD is owned by hedge funds
648
-5
95.21M
-852.64K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 10935 |
| Mar 2024 | 0 | 281 |
| Apr 2024 | 0 | 425 |
| May 2024 | 0 | 28043 |
| Jun 2024 | 0 | 15683 |
| Jul 2024 | 0 | 15683 |
| Aug 2024 | 0 | 74565 |
| Sep 2024 | 0 | 22683 |
| Oct 2024 | 0 | 21943 |
| Nov 2024 | 0 | 26708 |
| Dec 2024 | 0 | 3074 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | SANDERCOCK BRETT officer: Chief Fi.. | ResMed Common Stock | 1,000 | $244.23 | $244,230 | ||
Sale | SANDERCOCK BRETT officer: Chief Fi.. | ResMed Common Stock | 1,000 | $244.23 | $244,230 | ||
Sale | FARRELL PETER C director | ResMed Common Stock | 2,000 | $245.65 | $491,300 | ||
Sale | RIDER MICHAEL J officer: Global General Counsel | ResMed Common Stock | 74 | $248.91 | $18,419 | ||
Sale | FARRELL MICHAEL J. officer: Chief Ex.. | ResMed Common Stock | 2,000 | $249.67 | $499,330 | ||
Sale | LEONG JUSTIN officer: Chief Product Officer | ReMed Common Stock | 6,160 | $243.09 | $1,497,416 | ||
Sale | DE WITTE JAN director | ReMed Common Stock | 796 | $248.81 | $198,053 | ||
Sale | SANDERCOCK BRETT officer: Chief Fi.. | ResMed Common Stock | 1,000 | $249 | $249,000 | ||
Sale | SANDERCOCK BRETT officer: Chief Fi.. | ResMed Common Stock | 1,000 | $249 | $249,000 | ||
Option | FARRELL MICHAEL J. officer: Chief Ex.. | ResMed Common Stock | 14,683 | $84.98 | $1,247,761 |
| Patent |
|---|
Application Filling date: 16 Feb 2022 Issue date: 18 Aug 2022 |
Application Filling date: 24 Jul 2020 Issue date: 4 Aug 2022 |
Application Filling date: 28 Apr 2020 Issue date: 23 Jun 2022 |
Grant Filling date: 7 Sep 2020 Issue date: 21 Jun 2022 |
Grant Utility: Patient management system Filling date: 31 Jul 2015 Issue date: 21 Jun 2022 |
Application Filling date: 3 Mar 2022 Issue date: 16 Jun 2022 |
Application Filling date: 23 Feb 2022 Issue date: 9 Jun 2022 |
Grant Filling date: 31 Jul 2015 Issue date: 24 May 2022 |
Application Filling date: 13 Jan 2022 Issue date: 5 May 2022 |
Application SYSTEM AND METHODS FOR TRIGGERING SOUNDS TO MASK NOISE FROM RESPIRATORY SYSTEMS AND THEIR COMPONENTS Filling date: 26 Jun 2020 Issue date: 28 Apr 2022 |
| Quarter | Transcript |
|---|---|
| Q3 2024 25 Apr 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 24 Jan 2024 | Q2 2024 Earnings Call Transcript |
| Q1 2024 26 Oct 2023 | Q1 2024 Earnings Call Transcript |
| Q4 2023 3 Aug 2023 | Q4 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Michael J. Farrell BE, MBA, SM (1972) Chief Executive Officer & Director | $2,690,000 |
| Mr. Robert A. Douglas (1960) Pres & Chief Operating Officer | $1,940,000 |
| Dr. James R. Hollingshead Ph.D. (1963) Pres of Sleep & Respiratory Care Bus. | $1,430,000 |
| Mr. Brett A. Sandercock (1967) Chief Financial Officer | $1,010,000 |
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD (1942) Founder & Non-Executive Chairman | $441,460 |
ResMed: A Sleeping Giant Hiding In Plain Sight
ResMed: Cornering The Market In Sleep Solutions
Nyxoah: The Future Of OSA
ResMed: Potentially Undervalued Amid Increasing Sleep Apnea Awareness
ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
MoneyShow's Best Investment Ideas For 2024: Part 7
Why ResMed Is One Of My Top Picks In 2024
ResMed: A Buy For Investors Seeking Long-Term Rewards
ResMed: Down 60% With Tremendous Long-Term Potential
-
What's the price of ResMed stock today?
One share of ResMed stock can currently be purchased for approximately $283.7.
-
When is ResMed's next earnings date?
ResMed Inc. is estimated to report earnings on Wednesday, 22 Oct 2025.
-
Does ResMed pay dividends?
Yes, ResMed pays dividends and its trailing 12-month yield is 0.87% with 26% payout ratio. The last ResMed stock dividend of $0.42 was paid on 17 Mar 2022.
-
How much money does ResMed make?
ResMed has a market capitalization of 33.04B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.95% to 4.69B US dollars. ResMed earned 1.02B US dollars in net income (profit) last year or $2.2 on an earnings per share basis.
-
What is ResMed's stock symbol?
ResMed Inc. is traded on the NYSE under the ticker symbol "RMD".
-
What is ResMed's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of ResMed?
Shares of ResMed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ResMed's key executives?
ResMed's management team includes the following people:
- Mr. Michael J. Farrell BE, MBA, SM Chief Executive Officer & Director(age: 53, pay: $2,690,000)
- Mr. Robert A. Douglas Pres & Chief Operating Officer(age: 65, pay: $1,940,000)
- Dr. James R. Hollingshead Ph.D. Pres of Sleep & Respiratory Care Bus.(age: 62, pay: $1,430,000)
- Mr. Brett A. Sandercock Chief Financial Officer(age: 58, pay: $1,010,000)
- Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD Founder & Non-Executive Chairman(age: 83, pay: $441,460)
-
Is ResMed founder-led company?
Yes, ResMed is a company led by its founder Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD.
-
How many employees does ResMed have?
As Jul 2024, ResMed employs 10,140 workers.
-
When ResMed went public?
ResMed Inc. is publicly traded company for more then 30 years since IPO on 2 Jun 1995.
-
What is ResMed's official website?
The official website for ResMed is resmed.com.
-
Where are ResMed's headquarters?
ResMed is headquartered at 9001 Spectrum Center Boulevard, San Diego, CA.
-
How can i contact ResMed?
ResMed's mailing address is 9001 Spectrum Center Boulevard, San Diego, CA and company can be reached via phone at 858 836 5000.
-
What is ResMed stock forecast & price target?
Based on 4 Wall Street analysts` predicted price targets for ResMed in the last 12 months, the avarage price target is $233.5. The average price target represents a -17.69% change from the last price of $283.7.
ResMed company profile:
ResMed Inc.
resmed.comExchange:
NYSE
Full time employees:
9,980
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
9001 Spectrum Center Boulevard
San Diego, CA 92123
San Diego, CA 92123
CIK: 0000943819
ISIN: US7611521078
CUSIP: 761152107
